Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study

Clinical trial NCT01689389 · COMPLETED

Trial details

NCT number: NCT01689389
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Schizophrenia Bipolar Episodes

Start date: 2012-12-01
Primary completion: 2014-12-01
Enrollment: 2292

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.